about
Heart of the matter: coronary dysfunction in metabolic syndrome.Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure.Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz stent.Abnormal patterns of intraventricular flow and diastolic filling after the Fontan operation: evidence for incoordinate ventricular wall motion.Angiographic demonstration of incoordinate motion of the ventricular wall after the Fontan operation.The relationship of plasma volume, sympathetic tone, and proinflammatory cytokines in young healthy nonpregnant women.Coronary responses to cold air inhalation following afferent and efferent blockade.Centrally acting antihypertensive drugs: re-emergence of sympathetic inhibition in the treatment of hypertension.Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere.Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery.Evidence of left ventricular dysfunction in asymptomatic elderly patients with non-insulin-dependent diabetes mellitus.Inhibitory effects of glyceryl trinitrate on alpha-adrenoceptor mediated contraction in the human internal mammary arteryMyocardial contraction-relaxation couplingAutonomic activation links CNS oxygen toxicity to acute cardiogenic pulmonary injury.The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysisDobutamine-induced hyperaemia inversely correlates with coronary artery stenosis severity and highlights dissociation between myocardial blood flow and oxygen consumption.Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors.Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.A clinical algorithm to differentiate heart failure with a normal ejection fraction by pathophysiologic mechanism.Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.Temporary stent as a bail-out device during percutaneous transluminal coronary angioplasty: preliminary clinical experience.Left ventricular diastolic function in children measured by Doppler echocardiography: normal values and relation with growth.Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.Impairment of the myocardial vasomotor response to cold pressor stress in collateral dependent myocardium.Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases.Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography.Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillationThromboxane A2 receptor antagonists.Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.Intravenous phentolamine abolishes coronary vasoconstriction in response to mild central hypovolemia.Tolvaptan for the treatment of heart failure: a review of the literature.Cardioprotection by ivabradine through heart rate reduction and beyond.Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain.Calcium antagonists in myocardial ischemia/reperfusion--update 2012.ACE inhibitors for the treatment of myocardial ischemia?Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.
P2860
Q30404992-D51D4C0A-CE6A-4F6B-8D02-39873FA4AE29Q30417833-0396E43A-3CE4-4AB1-8427-5D8F9B6AB2A6Q33611664-248E6D47-0B7E-4DDD-A457-895A5C1FF79DQ33611717-1FFFE564-B0CC-485F-AA7D-5542814CA33BQ33611862-5A4FB377-7482-4360-8CA3-3ED933B94F71Q33870518-D3949474-5D5D-43E8-A330-63CCB3571972Q33913167-F8167609-AE9C-465A-B85C-00205657A8BBQ34028272-AE6296AB-D8D3-4D25-A567-6E121BBA6420Q34212291-B64E88D1-FAE9-498E-B3E7-2FED724B0B7EQ34345570-9827309E-E665-4264-886A-3CC96A881DD2Q34349703-B1D2EF3F-E0B1-493F-9CB2-1B66CB98C64FQ34403170-E8C32552-02EF-4BC8-BF40-A871C6C0A67DQ34426118-99009BBB-43BA-4920-B272-D36756FE5C4AQ34502166-312F0426-CF19-411A-A893-435D3359C2D2Q34971810-90697DEB-821C-421C-BC67-7FE848236D4EQ35772512-C84087DC-6EC1-44F1-8394-23172FA3AFDBQ36141242-46EC97CF-CB61-4DB7-BBC8-CE494854A2D6Q36329933-A54AECC0-F037-4A0A-83E9-7976F6E682F8Q36369715-CCD097DE-FA68-485E-AE58-758C13A6596FQ36811750-42695C6E-119B-4297-BD62-7E99CF398189Q36812661-B3C37FB4-14D9-42C9-A24E-C6DAA2847FB8Q36813356-3BFACDEC-1578-4BC7-9609-4A159702E3E4Q36817713-985D9485-C43C-4C39-8B50-45A9E36C601FQ36817729-9693E07C-C1DC-40EA-94C4-6D561B3B25A4Q36846219-155FC3A7-D90A-46DC-8401-ED8767DE6757Q36850177-84729790-0518-4207-B031-405A17D2DAD3Q36872695-4636703C-B3CF-495F-82C6-0F2E6E52947CQ37068649-EB4424F5-2317-4E6F-9147-477B81140635Q37106753-EEF61A91-1DF3-4A70-A259-025D51DB4B25Q37113049-5754C00E-7BD5-41A3-9D67-948568ABDDF7Q37143282-F5F3F978-CAC9-483F-BE39-E2C41F45C50BQ37279917-DBF27751-4A45-4BF9-9C74-7B42DFD8BF3DQ37578269-AED5844C-9D56-445C-BD73-F5F512B67879Q37852720-FFC51981-FE68-4D66-9437-A70C1988652AQ37912844-D5960CB8-24EB-4FDD-8E26-4C69AAF5D20CQ37923966-5D53B950-16A4-4ADF-B0DF-1347DBE2FBC3Q37988319-23F8CA2B-FD01-4DE8-B300-29038E551FF3Q38018510-FF4EBA4D-8177-475F-B24B-A563D59AB5E6Q38025697-359EDC92-D143-4BB7-A97F-3117F119AFC9Q38797276-8CFAAEC0-142F-4E8A-AB6C-A1F0F763B4DA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alpha-adrenergic mechanisms in myocardial ischemia.
@en
Alpha-adrenergic mechanisms in myocardial ischemia.
@nl
type
label
Alpha-adrenergic mechanisms in myocardial ischemia.
@en
Alpha-adrenergic mechanisms in myocardial ischemia.
@nl
prefLabel
Alpha-adrenergic mechanisms in myocardial ischemia.
@en
Alpha-adrenergic mechanisms in myocardial ischemia.
@nl
P356
P1433
P1476
Alpha-adrenergic mechanisms in myocardial ischemia.
@en
P2093
P356
10.1161/01.CIR.81.1.1
P407
P577
1990-01-01T00:00:00Z